Skip to main content
. 2000 Oct;157(4):1393–1403. doi: 10.1016/S0002-9440(10)64652-4

Table 1.

Clinical Data and Results of LOH Analysis for the Patients Involved in the Study of Expression and Imprinting

Case Age (months)/ sex Histology Chemo- therapy LOH D11S554 WT1 D11S1020 D11S1323 D11S1338 HBB HBE1 BWR1A D11S1318 TH IGF2 H19 DRD4 D11S1363 HRAS
D269 9 /F Mixed Yes No
D272 12 /M Mixed No No
D266 8 /F Mixed No No
D263 12 /M Epithelial No No
D166 48 /M Epithelial, multifocal Yes Yes ni ni ni ni ni ni ni ni
D23II 22 /M Epithelial No No
D195 19 /M Epithelial Yes No
D197 54 /M Epithelial Yes No
DZ18 6 /M Epithelial No Yes ni ni ni ni ni
M12 13 /M Epithelial No Yes ni
M14 20 /M Epithelial Yes No
D401 9 /F Mixed No No
D104 27 /F Epithelial No Yes ni ni ni ni
D199 25 /F Epithelial No No
D497 6 /F Epithelial Yes No
D268 6 /F Mixed No Yes ni ni ni ni ni
D161 11 /F Epithelial No No
DZ29II 13 /M Epithelial No No
DZ20 27 /F Epithelial, small cells No No
DZ25II 34 /F Epithelial, multifocal No Yes ni ni ni ni ni ni
D175 16 /M Epithelial No No
D204 4 /F Epithelial No No
D319 4 /M Epithelial No No
D399II 2 /M Epithelial No No

Information on the sample included in the examination of RNA expression and imprinting of p57KIP2, H19, and IGF2: clinical data, histological type, results of LOH studies on 11p15.5. Symbols and abbreviations: CL, cell line; ○, maintenance of heterozygosity; •, loss of heterozygosity; ni, noninformative; –, not done.